ストックスクリーナーアプリを入手
454.00
0.88%
-4.05
アフターアワーズ：
457.83
3.83
+0.84%
Vertex Pharmaceuticals Inc (VRTX) 最新ニュース
How Vertex’s IgA Nephropathy Data and Accelerated FDA Pathway At Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story - Yahoo Finance
Best Growth Stock to Buy Right Now: Eli Lilly vs. Vertex Pharmaceuticals - AOL.com
Cooper Financial Group Acquires 3,021 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock faces pressure amid CF dominance and pipeline uncertainties in 2026 - AD HOC NEWS
Vertex Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:VRTX - Benzinga
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 4 March - Investing.com
Oppenheimer upgrades Vertex Pharmaceuticals (VRTX) - MSN
Promising Biotech Stocks To Follow TodayMarch 20th - MarketBeat
Vertex Pharma stock faces pressure amid CF growth and pipeline uncertainties - AD HOC NEWS
Is CRISPR Therapeutics Stock a Buy Now? - AOL.com
Vertex Stock Falls 4.8% in a Month: Buying Opportunity or Red Flag? - TradingView
My Top 3 Drug Stocks for March 2026 - The Motley Fool
CIBC Bancorp USA Inc. Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Is Vertex Pharmaceuticals (VRTX) Offering Value After Recent Share Price Pullback? - simplywall.st
Assessing Vertex Pharmaceuticals (VRTX) Valuation After Positive RAINIER Trial Update And Accelerated IgAN Filing - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
RBC Capital reiterates Vertex stock rating on competitive concerns - Investing.com
Swiss Life Asset Management Ltd Buys 6,045 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Groupama Asset Management Trims Stake in Vertex Pharmaceuticals - National Today
Wells Fargo Adjusts PT on Vertex Pharmaceuticals to $550 From $515, Maintains Overweight Rating - marketscreener.com
Argus Adjusts PT on Vertex Pharmaceuticals to $520 From $475, Maintains Buy Rating - marketscreener.com
Mirabella Financial Services LLP Raises Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Argus raises Vertex stock price target to $520 on CF franchise - Investing.com
VRTX SEC FilingsVertex Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Groupama Asset Managment Sells 17,916 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Stock In Shambles: Down 9.5% With 6-Day Losing Streak - Trefis
Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls -9.5% - Trefis
Danske Bank A S Makes New $64.42 Million Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by AIA Group Ltd - MarketBeat
Vertex Pharmaceuticals (VRTX) Upgraded to Buy by Maxim Group | V - GuruFocus
Vertex Pharmaceuticals (VRTX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vertex Pharmaceuticals (VRTX) Gains Amid Optimistic Outlook and Upgrade - GuruFocus
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks - Yahoo Finance
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to "Buy" at Maxim Group - MarketBeat
Vertex Pharmaceuticals Stock Slides 7.3% With A 5-Day Losing Spree - Trefis
Vertex Pharmaceuticals Stock Plummets -7.3% With 5-Day Losing Streak - Trefis
Vertex Pharmaceuticals Incorporated $VRTX is Provident Investment Management Inc.'s 4th Largest Position - MarketBeat
Fierce Biotech Layoff Tracker 2026: Gossamer lays off 48%; Bicycle deflates - Fierce Biotech
Physician Views Preview: How clinically meaningful are Vertex's Phase III data for povetacicept? - FirstWord Pharma
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals (NASDAQ:VRTX) CMO Carmen Bozic Sells 2,329 Shares - MarketBeat
Vertex Pharmaceuticals EVP and CMO Carmen Bozic Sells Shares - TradingView
Vertex (VRTX) EVP and CMO Carmen Bozic sells 2,329 shares in pre-set 10b5-1 trade - Stock Titan
Top Biotech Stocks To Follow TodayMarch 17th - MarketBeat
Mirabella Financial Services LLP Has $2.10 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Focus Partners Wealth Trims Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Bamco Inc. NY Trims Stake in Vertex Pharmaceuticals - National Today
Bank of Nova Scotia Increases Stake in Vertex Pharmaceuticals - National Today
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Bamco Inc. NY - MarketBeat
Bank of Nova Scotia Buys 36,643 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by California Public Employees Retirement System - MarketBeat
Aquatic Capital Management Boosts Vertex Pharmaceuticals Stake - National Today
Aquatic Capital Management LLC Acquires Shares of 29,596 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Layoff Tracker: Inovio Slims Down as Lead Asset Nears Market - BioSpace
S&P 500 Dips 0.21% as Vertex Pharmaceuticals Soars 8.31% Amid Market Struggles - Markets Mojo
Is Vertex Pharmaceuticals Heading to $600? - The Motley Fool
The week in pharma: action, reaction and insight – week to March 13, 2026 - The Pharma Letter
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Chevy Chase Trust Holdings LLC - MarketBeat
Banco Bilbao Vizcaya Argentaria S.A. Boosts Vertex Pharmaceuticals Stake - National Today
Banco Bilbao Vizcaya Argentaria S.A. Buys 4,464 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Ameriprise Financial Inc. - MarketBeat
Aristotle Atlantic Partners LLC Decreases Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Alliancebernstein L.P. Acquires 144,266 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex rises as kidney drug meets goal in late-stage trial - MSN
Vertex Pharmaceuticals Incorporated $VRTX Shares Sold by Wellington Management Group LLP - MarketBeat
0.62%
0.34%
大文字化:
|
ボリューム (24 時間):